Quarterly report [Sections 13 or 15(d)]

Consolidated Balance Sheets

v3.25.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 102,773 $ 118,575
Short-term restricted cash 1,267 1,003
Accounts receivable, net 98,925 85,464
Inventory 86,005 90,343
Prepaid expenses and other current assets 31,436 28,057
Total current assets 320,406 323,442
Long-term restricted cash 25 25
Property and equipment, net 55,546 59,300
Leased right-of-use assets 17,939 18,184
Intangible assets, net 51,587 55,008
Goodwill 318,588 318,588
Deferred tax assets 69,345 68,662
Other long-term assets 21,845 21,430
Total assets 855,281 864,639
Current liabilities:    
Accounts payable 18,355 31,378
Accrued price protection liability 47,683 43,401
Accrued expenses and other current liabilities 106,994 87,408
Accrued compensation 23,861 20,097
Total current liabilities 196,893 182,284
Long-term lease liabilities 15,774 16,952
Long-term debt 123,150 122,996
Other long-term liabilities 26,289 26,124
Total liabilities 362,106 348,356
Commitments and contingencies
Stockholders’ equity:    
Preferred stock, $0.0001 par value; 25,000 shares authorized, no shares issued or outstanding 0 0
Common stock, $0.0001 par value; 550,000 shares authorized; 86,374 shares issued and outstanding at March 31, 2025 and 84,613 shares issued and outstanding December 31, 2024 9 8
Additional paid-in capital 912,570 886,823
Accumulated other comprehensive loss (5,966) (6,823)
Accumulated deficit (413,438) (363,725)
Total stockholders’ equity 493,175 516,283
Total liabilities and stockholders’ equity $ 855,281 $ 864,639